COMMUNIQUÉS West-GlobeNewswire
-
Neocis and Yomi® S Named Winner of the 2026 TAG Awards for MedTech in Robotic & Procedural Innovation
23/04/2026 -
SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026
23/04/2026 -
Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing
23/04/2026 -
Codexis to Report First Quarter 2026 Financial Results on May 7
23/04/2026 -
Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States
23/04/2026 -
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
23/04/2026 -
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
23/04/2026 -
RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting
23/04/2026 -
Atsena Therapeutics Announces Upcoming Presentations at Scientific and Medical Meetings
23/04/2026 -
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
23/04/2026 -
Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
23/04/2026 -
NEW YORK PLASTIC SURGICAL GROUP ANNOUNCES OPENING OF HARRISON, NY LOCATION
23/04/2026 -
electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation
23/04/2026 -
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
23/04/2026 -
CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
23/04/2026 -
CytoDyn to Host Investor Webcast
23/04/2026 -
MAPS Celebrates 40 Years at a Defining Moment for Psychedelics
23/04/2026 -
Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform
23/04/2026 -
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
23/04/2026
Pages